Stephen Squinto

2019

In 2019, Stephen Squinto earned a total compensation of $2.1M as Former Interim Chief Executive Officer and former Acting Head of Research and Development at Passage BIO.

Compensation breakdown

Non-Equity Incentive Plan$127,406
Option Awards$1,787,945
Salary$225,000
Total$2,140,351

Squinto received $1.8M in option awards, accounting for 84% of the total pay in 2019.

Squinto also received $127.4K in non-equity incentive plan and $225K in salary.

Rankings

In 2019, Stephen Squinto's compensation ranked 5,574th out of 13,971 executives tracked by ExecPay. In other words, Squinto earned more than 60.1% of executives.

ClassificationRankingPercentile
All
5,574
out of 13,971
60th
Division
Manufacturing
2,086
out of 5,701
63rd
Major group
Chemicals And Allied Products
743
out of 2,200
66th
Industry group
Drugs
623
out of 1,886
67th
Industry
Biological Products, Except Diagnostic Substances
150
out of 389
61st
Source: SEC filing on April 14, 2021.

Squinto's colleagues

We found one more compensation record of an executive who worked with Stephen Squinto at Passage BIO in 2019.

2019

Gary Romano

Passage BIO

Chief Medical Officer

News

In-depth

You may also like